1-7 of 7
her2 positive
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Exceptionally Potent Cytotherapy Using T Cells Armed with Novel Tetravalent Recombinant Bispecific Antibodies Specific for GD2 and HER2

Jeong A Park, MD PhD, Hong Xu, PhD, Brian Santich, PhD, Nai-Kong V. Cheung, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4536.
https://doi.org/10.1182/blood-2018-99-120210
Published: 2018
Journal Articles

Copper-64-Labeled Daratumumab As a PET Imaging Tracer for Multiple Myeloma: Potential Use for Minimal Residual Disease Detection

Enrico Caserta, PhD, Junie Chea, Megan Minnix, Domenico Viola, BS, Steven Vonderfecht, Jonathan J Keats, PhD, James F Sanchez, David Colcher, John E. Shively, Amrita Krishnan, MD, Flavia Pichiorri, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3083.
https://doi.org/10.1182/blood.V130.Suppl_1.3083.3083
Published: 2017
Journal Articles

In Vitro Comparison of ADCC and CAR Sensitivity of Adult HER-2+ B-ALL Using the NK-92 Human Cell Line Transduced with a Human CD16 (ADCC) or an Anti-HER2 Chimeric Antigen Receptor (CAR)

Beatrice Clemenceau, PhD, Thierry Guillaume, MD PhD, Nelly Robillard, PhD, Regine Vivien, Pierre Peterlin, MD, Alice Garnier, MD, Marie-Christine Bene, Henri Vié, PhD, Patrice Chevallier, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5193.
https://doi.org/10.1182/blood.V128.22.5193.5193
Published: 2016
Journal Articles

Synergistic Antitumor Effects of Chimeric Antigen Receptor-Modified T Cells and Oncolytic Virotherapy

Xingbing Wang, PhD MD, Stephen Gottschalk, MD, Xiao-Tong Song, PhD
Journal: Blood
Blood (2014) 124 (21): 5808.
https://doi.org/10.1182/blood.V124.21.5808.5808
Published: 2014
Journal Articles

Therapy-Related Myeloid Neoplasms in Breast Cancer Patients: A Single-Institution Report of 150 Cases

Katarina Sevcikova, MD, Zuo Zhuang, MD PhD, Guillermo Garcia-Manero, MD, Ricardo Alvarez, MD, Hagop M. Kantarjian, MD, Mego Michal, MD, Constance Albarracin, MD PhD, Guilin Tang, MD, Sara S. Strom, PhD, James M. Reuben, PhD, Joseph D Khoury, MD
Journal: Blood
Blood (2014) 124 (21): 962.
https://doi.org/10.1182/blood.V124.21.962.962
Published: 2014
Journal Articles

Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study

Brief Report
Patrice Chevallier, Nelly Robillard, Aude Charbonnier, Emmanuel Raffoux, Sebastien Maury, Sylvain Carras, Cecile Chabrot, Cecile Fohrer, Marc Bernard, Jean-Sebastien Blade, Anne Etienne, Pascaline Talmant, Jacques Delaunay, Thierry Guillaume, Mohamad Mohty, Marie-Christine Bene, Norbert Ifrah, Herve Dombret
Journal: Blood
Blood (2012) 119 (11): 2474–2477.
https://doi.org/10.1182/blood-2011-11-390781
Published: 2012
Journal Articles

Trastuzumab (Herceptin®) for Treatment of Refractory/Relapsed HER2 Positive Adult B-ALL: Results of a Phase II GRAALL Study

Patrice Chevallier, MD, Nelly Robillard, Aude Charbonnier, Emmanuel Raffoux, MD, PhD, Sébastien Maury, Sylvain Carras, Cecile Chabrot, Cecile Fohrer, Marc Bernard, Jean-Sebastien Blade, Anne Etienne, MD, Pascaline Talmant, Jacques Delaunay, Thierry Guillaume, Mohamad Mohty, Norbert Ifrah, Herve Dombret
Journal: Blood
Blood (2011) 118 (21): 1525.
https://doi.org/10.1182/blood.V118.21.1525.1525
Published: 2011